# Pilot Trial of Arsenic + Cytarabine in Patients With Myelofibrosis

> **NCT00572065** · EARLY_PHASE1 · COMPLETED · sponsor: **Weill Medical College of Cornell University** · enrollment: 21 (actual)

## Conditions studied

- Myelofibrosis

## Interventions

- **DRUG:** arsenic trioxide
- **DRUG:** cytarabine

## Key facts

- **NCT ID:** NCT00572065
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02-29
- **Primary completion:** 2009-12
- **Final completion:** 2010-02-08
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2017-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00572065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00572065, "Pilot Trial of Arsenic + Cytarabine in Patients With Myelofibrosis". Retrieved via AI Analytics 2026-08-19 from https://api.ai-analytics.org/clinical/NCT00572065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*